BiotechTube
Home/Eledon Pharmaceuticals/David-Alexandre C. Gros, MD
DC

David-Alexandre C. Gros, MD

Chief Executive Officer

Eledon Pharmaceuticals

Therapeutic Areas

TransplantationAutoimmune DiseasesNeurodegenerative Diseases

Eledon Pharmaceuticals Pipeline

DrugIndicationPhase
TegoprubartKidney Transplant (Allotransplantation)Phase 2

Leadership Team at Eledon Pharmaceuticals

SP
Steven Perrin, PhD
President and Chief Scientific Officer
View full Eledon Pharmaceuticals profile